ArticleOncology reports2026

FXYD5 promotes the growth of glioblastoma by targeting the PI3K/AKT/ACSL4 signaling axis.

Bang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.